Tag Archives: Fosamax
Bisphosphonates May Lower the Risk for Colorectal Cancer
A new study suggested taking bisphosphonates for osteoporosis for more than a year may reduce the risk for colorectal cancer by 60%. The results came from an analysis of postmenopausal women who took bisphosphonates, such as alendronate (Fosamax), for more … Continue reading →
Posted in Breast cancer, Cancer, Colorectal cancer
|
Tagged alendronate, AZURE, Bisphosphonates, Breast cancer, colorectal cancer, Fosamax, Postmenopausal, zolendronic acid, Zometa
|
Comments Off on Bisphosphonates May Lower the Risk for Colorectal Cancer